Promentis Pharmaceuticals Lands $8,787,399 New Round

  • Feed Type
  • Date
  • Company Name
    Promentis Pharmaceuticals
  • Mailing Address
    826 N. Plankinton Ave. Milwaukee, WI 53203 USA
  • Company Description
    Promentis Pharmaceuticals, Inc. is a pharmaceutical company developing novel compounds for the treatment of schizophrenia and other central nervous system disorders.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 8 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy